Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
As of close of business last night, Edgewise Therapeutics Inc’s stock clocked out at $23.27, down -0.73% from its previous closing price of $23.44. In other words, the price has decreased by -$0.73 from its previous closing price. On the day, 0.7 million shares were traded. EWTX stock price reached its highest trading level at $23.48 during the session, while it also had its lowest trading level at $22.62.
Ratios:
To gain a deeper understanding of EWTX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 19.93 and its Current Ratio is at 19.93. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Scotiabank on March 07, 2025, initiated with a Sector Outperform rating and assigned the stock a target price of $50.
On January 22, 2025, Stifel started tracking the stock assigning a Hold rating and target price of $30.
On November 22, 2024, Evercore ISI started tracking the stock assigning a Outperform rating and target price of $45.Evercore ISI initiated its Outperform rating on November 22, 2024, with a $45 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 07 ’25 when Russell Alan J sold 200 shares for $30.02 per share. The transaction valued at 6,004 led to the insider holds 14,863 shares of the business.
KOCH KEVIN sold 100 shares of EWTX for $3,000 on Mar 07 ’25. The President and CEO now owns 14,478 shares after completing the transaction at $30.00 per share. On Feb 05 ’25, another insider, Russell Alan J, who serves as the Chief Scientific Officer of the company, sold 8,015 shares for $30.02 each. As a result, the insider received 240,623 and left with 14,863 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EWTX now has a Market Capitalization of 2215427328 and an Enterprise Value of 1749993984.
Stock Price History:
The Beta on a monthly basis for EWTX is 0.28, which has changed by 0.29134297 over the last 52 weeks, in comparison to a change of 0.06429911 over the same period for the S&P500. Over the past 52 weeks, EWTX has reached a high of $38.12, while it has fallen to a 52-week low of $14.90. The 50-Day Moving Average of the stock is -11.50%, while the 200-Day Moving Average is calculated to be -8.53%.
Shares Statistics:
It appears that EWTX traded 1.16M shares on average per day over the past three months and 1466910 shares per day over the past ten days. A total of 94.84M shares are outstanding, with a floating share count of 67.23M. Insiders hold about 29.38% of the company’s shares, while institutions hold 78.78% stake in the company. Shares short for EWTX as of 1741910400 were 9088389 with a Short Ratio of 7.82, compared to 1739491200 on 8057846. Therefore, it implies a Short% of Shares Outstanding of 9088389 and a Short% of Float of 13.919999999999998.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
